Global Bone Growth Stimulator Market Overview

The Bone Growth Stimulator Market was estimated at USD 1.04 Billion in 2021 and is projected to reach USD 1.39 Billion by 2028, growing at a CAGR of 4.2% over the analysis period.

Bones are connected with muscles and joints to hold the body together and support freedom of movement. This unison is called the musculoskeletal system. The skeleton protects vital internal organs such as the brain, heart, and lungs as well supports and shapes the body. Bones are made of calcium, magnesium, and phosphorous. Bones play an important role in our day-to-day activities, however, after a bone injury occurs it takes time for bones to repair on their own. Bone growth stimulation represents a therapy that assists in bone healing after a fracture and spinal fusion surgical process. Naturally, the human body heals damaged or fractured bones however, in individuals with diabetes, poor nutrition, low vitamin D level, and in the aged population, the natural process of bone healing is disrupted. In these people natural healing doesn't take place thus, bone growth stimulators are utilized in such situations. The device segment of bone growth stimulators utilizes electric current to promote bone growth. The electric current is generated by ultrasonic or electromagnetic waves. The growing number of orthopedic disorders is the vital factor propelling the growth of the bone growth stimulator market over the forecasted period.

Market Dynamics And Key Factors For Bone Growth Stimulator Market

Drivers:

Factors such as the aging population, rising incidence of orthopedic disorders such as osteoporosis and degenerative joint disorders, and a preference for minimally or non-invasive surgeries are all contributing to market growth. The rising frequency of orthopedic disorders, coupled with the high uptake of therapy in healthcare facilities, ensures the growth of the market in the forecasted period. An increase in the number of accidents and trauma cases is expected to further boost the market's growth. Road accidents, along with trauma, can result in serious spinal injuries, as well as delayed union and non-union fractures, requiring surgery. Bone growth stimulators use electrical current or ultrasonic waves to encourage bone healing during treatments for union and non-union fractures, fresh fractures, and failed spinal fusions.

As these are minimally invasive surgical procedures there has been an upsurge in their demand. Fewer operating complications, shorter hospitalization, less pain, smaller and more cosmetic incisions, lower risk of infection, reduced postoperative care, and faster recovery are all advantages of minimally invasive treatments. Advanced technology is used in minimally invasive treatments to detect and treat a variety of disorders, including cancer. These treatments are intended to remove malignant tumors and lymph nodes from the body without leaving scars. Thus, the growing popularity of minimally invasive surgical procedures is further promoting the expansion of the bone growth stimulator market.

Restraints:

Inflexible reimbursement policies are one of the factors hampering the growth of the bone growth stimulator market over the analysis period. The majority of insurance service providers offer policies under specific criteria. However, in developing regions as well as in developed regions private insurance providers do not include insurance or reimbursement policies for bone growth stimulation surgeries. Moreover, the growing competition among key market layers has resulted in the production of several devices. However, there has been an upsurge in product recalls across the globe, thereby restraining the development of the bone growth stimulator market.

Opportunities:

The untapped markets in Asia-Pacific, Middle East & Africa, and Latin America provide a lucrative opportunity for market players. The market in these regions has a large scope as governments are heavily investing in the development of healthcare infrastructure. The Asia-Pacific region has the highest population pool as India and China are the two most densely populated countries in the world. Growing awareness of the latest treatment options for spinal fusion and bone healing among physicians, surgeons, and patients is likely to drive demand for bone growth stimulation products in these regions. Furthermore, many patients from developed countries are reported to travel to these emerging markets for medical care because of the huge cost savings.

Market Segmentation

Segmentation Analysis of Bone Growth Stimulator Market:

By Product, the device segment is expected to lead the bone growth stimulator market over the analysis period. This segment is projected to grow at a CAGR of 4.3% and generate revenue of USD 739 million by the end of the analysis period. These devices can be implanted as well placed on the outer side of the damaged region. It generates electrical or ultrasonic current to heal fractures or fusions. The growing geriatric population and the rising preference for minimally invasive surgical procedures for the treatment of orthopedic disorders are the main factors supporting the growth of the device segment over the projected period.

By Application, the spinal fusion segment is predicted to dominate the bone growth stimulator market. The rise in the number of spine disorders and the effectiveness of bone growth stimulators on the cervical and lumbar spine has shown significant beneficial fusion results. Spinal fusion surgeries are performed to connect two or more vertebrae permanently thus eliminating the motion between them. The usage of bone growth stimulators can be utilized in post-operative conditions to stimulate the natural growth process of bone. The number of individuals undergoing spinal fusion surgeries has increased owing to the 79 to 905 success rate of the procedures thus, strengthening the development of the segment.

By End-Users, the hospitals & ASCs segment is predicted to have the lion's share of the bone growth stimulator market. Hospitals employ bone growth stimulation products for a variety of procedures, including spine surgery, oral and maxillofacial surgery, dental practices, and bone fractures. In 2021, hospitals and ASCs held the largest proportion of the bone growth stimulators market. The key factors driving the growth of the bone growth stimulators market for hospitals and ASCs are the advantages of bone growth stimulation products over their counterparts, the rising patient population, growing procedural volumes of spinal fusion surgeries, growing prevalence of spinal disorders, and growing awareness of bone growth stimulation products.

Regional Analysis of Bone Growth Stimulator Market:

The North American region is anticipated to have the highest share of the bone growth stimulator market during the forecast period. The market in the USA was estimated at USD 527.7 million in 2021. The development in this region is highly attributed to the presence of prominent players in this region. The high competitiveness in this region has resulted in the development of new devices utilized in bone growth stimulators. For instance, Orthofix International's portfolio for bone growth stimulators comprises of CervicalStim and SpinalStim. The CervicalStim device is the only FDA-approved bone stimulator in the market utilized for cervical fusion. Similar product launches and the growing prevalence of orthopedic disorders in this region have boosted the growth of the bone growth stimulator market in this region.

The European region is anticipated to have the second-highest share of the bone growth stimulator market in the projected period. The total number of fragility fractures in this region is estimated to increase from 2.7 million in 2017 to 3 million by the end of 2030. With this rise in the number of fragility fractures, the annual fracture-related cost is anticipated to increase by 27%, which was USD 42.5 billion in 2017. It is estimated that 5.5 million men and 22 million women suffer from bone disorders in the EU alone. Moreover, the growing awareness among individuals about the benefits of bone growth stimulators has propelled the growth of the bone growth stimulator market in this region.

The bone growth stimulator market in the Asia-Pacific region is expected to develop at the highest CAGR over the analysis period. The growth in this region is attributed to the increasing foreign investment and the development of high-quality healthcare infrastructure. The increased incidence of spinal disorders, growing geriatric population, increasing population exposure to key risk factors (such as obesity, smoking, and diabetes), and rising patient demand for minimally invasive orthopedic therapy are contributing to the expansion of the market in this region. In India, 354,796 cases of road accidents were reported in 2020. Thus, road accidents and the rising amount of arthritis in this region are supporting the growth of the bone growth stimulator market in this region.

COVID-19 Impact Analysis on Bone Growth Stimulator Market

Surgical specialties face new challenges due to the rapid spread of SARS-COV-2 (COVID-19). These disruptions made clinicians widely consider non-operative treatment options to help manage patient symptoms and offer therapeutic care instead of the traditional surgical management of the given disorder. Most of the healthcare systems around the globe were overfilled with COVID-19 patients. Moreover, to curb the spread of the virus, most non-elective bone surgical procedures were postponed. The manufacturing of devices required for bone growth stimulators was halted due to the unavailability of laborers. In addition, there was a shortage of raw materials required for the production of devices. The consequences of the COVID-19 pandemic and the restricted elective capacity during the initial harsh restrictions may become more apparent shortly in the form of longer treatment waits, which could result in illness worsening and higher mortality owing to delayed diagnosis and treatment. To summarize, the COVID-19 pandemic severely affected the treatment procedures of bones utilizing bone growth stimulators.

Players Covered in Bone Growth Stimulator Market are:

• Arthrex Inc. (US)
• Terumo Corporation (Japan)
• Bioventus Inc. (US)
• Medtronic plc (Ireland)
• Orthofix International N.V (US)
• DePuy Synthes Companies (US)
• Synergy Orthopedics (US)
• Elizur Corporation (US)
• Ossatec Benelux B.V. (Netherlands)
• DJO LLC (US)
• Stryker Corporation (US)
• Zimmer Biomet Holdings Inc. (US) and other major players.

Recent Industry Developments In Bone Growth Stimulator Market

• In January 2022, Medtronic plc announced the results from an on-label, prospective, multi-center study showing positive effects of DTM™ SCS endurance therapy on chronic overall, back or leg pain. The study showed that 69% of the patients shifted to a less disabled category as measured by the Oswestry Disability Index, and 75% of patients were very satisfied with the therapy.
• In March 2021, Bioventus Inc. acquired Bioness Incorporation, a global leader in supplying medical equipment for neuromodulation and rehabilitation, through its revolutionary peripheral nerve stimulation ("PNS") therapy and premium rehabilitation solutions. With this acquisition, Bioventus will have access to all the pipeline products including patented electrical stimulation exoskeletal devices.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Product
 3.2 By Application
 3.3 By End Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Bone Growth Stimulator Market by Product
 5.1 Bone Growth Stimulator Market Overview Snapshot and Growth Engine
 5.2 Bone Growth Stimulator Market Overview
 5.3 Device
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Device: Grographic Segmentation
 5.4 Bone Morphogenetic Protein
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Bone Morphogenetic Protein: Grographic Segmentation
 5.5 Platelet-Rich Plasma
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Platelet-Rich Plasma: Grographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Grographic Segmentation

Chapter 6: Bone Growth Stimulator Market by Application
 6.1 Bone Growth Stimulator Market Overview Snapshot and Growth Engine
 6.2 Bone Growth Stimulator Market Overview
 6.3 Spinal Fusion Surgeries
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Spinal Fusion Surgeries: Grographic Segmentation
 6.4 Oral & Maxillofacial Surgeries
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Oral & Maxillofacial Surgeries: Grographic Segmentation
 6.5 Union & Non-Union Bone Fractures
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Union & Non-Union Bone Fractures: Grographic Segmentation
 6.6 Other
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Other: Grographic Segmentation

Chapter 7: Bone Growth Stimulator Market by End Users
 7.1 Bone Growth Stimulator Market Overview Snapshot and Growth Engine
 7.2 Bone Growth Stimulator Market Overview
 7.3 Hospitals & ASC’s
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals & ASC’s: Grographic Segmentation
 7.4 Home Care
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Home Care: Grographic Segmentation
 7.5 Research Institutes
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Research Institutes: Grographic Segmentation
 7.6 Others
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Bone Growth Stimulator Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Bone Growth Stimulator Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Bone Growth Stimulator Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 ARTHREX INC.
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 TERUMO CORPORATION
 8.4 BIOVENTUS INC.
 8.5 MEDTRONIC PLC.
 8.6 ORTHOFIX INTERNATIONAL N.V
 8.7 DEPUY SYNTHES COMPANIES
 8.8 SYNERGY ORTHOPEDICS
 8.9 ELIZUR CORPORATION
 8.10 OSSATEC BENELUX B.V.
 8.11 DJO LLC
 8.12 STRYKER CORPORATION
 8.13 ZIMMER BIOMET HOLDINGS INC.
 8.14 OTHER MAJOR PLAYERS

Chapter 9: Global Bone Growth Stimulator Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Product
  9.2.1 Device
  9.2.2 Bone Morphogenetic Protein
  9.2.3 Platelet-Rich Plasma
  9.2.4 Others
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Spinal Fusion Surgeries
  9.3.2 Oral & Maxillofacial Surgeries
  9.3.3 Union & Non-Union Bone Fractures
  9.3.4 Other
 9.4 Historic and Forecasted Market Size By End Users
  9.4.1 Hospitals & ASC’s
  9.4.2 Home Care
  9.4.3 Research Institutes
  9.4.4 Others

Chapter 10: North America Bone Growth Stimulator Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Product
  10.4.1 Device
  10.4.2 Bone Morphogenetic Protein
  10.4.3 Platelet-Rich Plasma
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Spinal Fusion Surgeries
  10.5.2 Oral & Maxillofacial Surgeries
  10.5.3 Union & Non-Union Bone Fractures
  10.5.4 Other
 10.6 Historic and Forecasted Market Size By End Users
  10.6.1 Hospitals & ASC’s
  10.6.2 Home Care
  10.6.3 Research Institutes
  10.6.4 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Bone Growth Stimulator Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Product
  11.4.1 Device
  11.4.2 Bone Morphogenetic Protein
  11.4.3 Platelet-Rich Plasma
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Spinal Fusion Surgeries
  11.5.2 Oral & Maxillofacial Surgeries
  11.5.3 Union & Non-Union Bone Fractures
  11.5.4 Other
 11.6 Historic and Forecasted Market Size By End Users
  11.6.1 Hospitals & ASC’s
  11.6.2 Home Care
  11.6.3 Research Institutes
  11.6.4 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Bone Growth Stimulator Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Product
  12.4.1 Device
  12.4.2 Bone Morphogenetic Protein
  12.4.3 Platelet-Rich Plasma
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Spinal Fusion Surgeries
  12.5.2 Oral & Maxillofacial Surgeries
  12.5.3 Union & Non-Union Bone Fractures
  12.5.4 Other
 12.6 Historic and Forecasted Market Size By End Users
  12.6.1 Hospitals & ASC’s
  12.6.2 Home Care
  12.6.3 Research Institutes
  12.6.4 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Bone Growth Stimulator Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Product
  13.4.1 Device
  13.4.2 Bone Morphogenetic Protein
  13.4.3 Platelet-Rich Plasma
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Spinal Fusion Surgeries
  13.5.2 Oral & Maxillofacial Surgeries
  13.5.3 Union & Non-Union Bone Fractures
  13.5.4 Other
 13.6 Historic and Forecasted Market Size By End Users
  13.6.1 Hospitals & ASC’s
  13.6.2 Home Care
  13.6.3 Research Institutes
  13.6.4 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Bone Growth Stimulator Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Product
  14.4.1 Device
  14.4.2 Bone Morphogenetic Protein
  14.4.3 Platelet-Rich Plasma
  14.4.4 Others
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Spinal Fusion Surgeries
  14.5.2 Oral & Maxillofacial Surgeries
  14.5.3 Union & Non-Union Bone Fractures
  14.5.4 Other
 14.6 Historic and Forecasted Market Size By End Users
  14.6.1 Hospitals & ASC’s
  14.6.2 Home Care
  14.6.3 Research Institutes
  14.6.4 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BONE GROWTH STIMULATOR MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BONE GROWTH STIMULATOR MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BONE GROWTH STIMULATOR MARKET COMPETITIVE RIVALRY
TABLE 005. BONE GROWTH STIMULATOR MARKET THREAT OF NEW ENTRANTS
TABLE 006. BONE GROWTH STIMULATOR MARKET THREAT OF SUBSTITUTES
TABLE 007. BONE GROWTH STIMULATOR MARKET BY PRODUCT
TABLE 008. DEVICE MARKET OVERVIEW (2016-2028)
TABLE 009. BONE MORPHOGENETIC PROTEIN MARKET OVERVIEW (2016-2028)
TABLE 010. PLATELET-RICH PLASMA MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. BONE GROWTH STIMULATOR MARKET BY APPLICATION
TABLE 013. SPINAL FUSION SURGERIES MARKET OVERVIEW (2016-2028)
TABLE 014. ORAL & MAXILLOFACIAL SURGERIES MARKET OVERVIEW (2016-2028)
TABLE 015. UNION & NON-UNION BONE FRACTURES MARKET OVERVIEW (2016-2028)
TABLE 016. OTHER MARKET OVERVIEW (2016-2028)
TABLE 017. BONE GROWTH STIMULATOR MARKET BY END USERS
TABLE 018. HOSPITALS & ASC’S MARKET OVERVIEW (2016-2028)
TABLE 019. HOME CARE MARKET OVERVIEW (2016-2028)
TABLE 020. RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA BONE GROWTH STIMULATOR MARKET, BY PRODUCT (2016-2028)
TABLE 023. NORTH AMERICA BONE GROWTH STIMULATOR MARKET, BY APPLICATION (2016-2028)
TABLE 024. NORTH AMERICA BONE GROWTH STIMULATOR MARKET, BY END USERS (2016-2028)
TABLE 025. N BONE GROWTH STIMULATOR MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE BONE GROWTH STIMULATOR MARKET, BY PRODUCT (2016-2028)
TABLE 027. EUROPE BONE GROWTH STIMULATOR MARKET, BY APPLICATION (2016-2028)
TABLE 028. EUROPE BONE GROWTH STIMULATOR MARKET, BY END USERS (2016-2028)
TABLE 029. BONE GROWTH STIMULATOR MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC BONE GROWTH STIMULATOR MARKET, BY PRODUCT (2016-2028)
TABLE 031. ASIA PACIFIC BONE GROWTH STIMULATOR MARKET, BY APPLICATION (2016-2028)
TABLE 032. ASIA PACIFIC BONE GROWTH STIMULATOR MARKET, BY END USERS (2016-2028)
TABLE 033. BONE GROWTH STIMULATOR MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA BONE GROWTH STIMULATOR MARKET, BY PRODUCT (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA BONE GROWTH STIMULATOR MARKET, BY APPLICATION (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA BONE GROWTH STIMULATOR MARKET, BY END USERS (2016-2028)
TABLE 037. BONE GROWTH STIMULATOR MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA BONE GROWTH STIMULATOR MARKET, BY PRODUCT (2016-2028)
TABLE 039. SOUTH AMERICA BONE GROWTH STIMULATOR MARKET, BY APPLICATION (2016-2028)
TABLE 040. SOUTH AMERICA BONE GROWTH STIMULATOR MARKET, BY END USERS (2016-2028)
TABLE 041. BONE GROWTH STIMULATOR MARKET, BY COUNTRY (2016-2028)
TABLE 042. ARTHREX INC.: SNAPSHOT
TABLE 043. ARTHREX INC.: BUSINESS PERFORMANCE
TABLE 044. ARTHREX INC.: PRODUCT PORTFOLIO
TABLE 045. ARTHREX INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. TERUMO CORPORATION: SNAPSHOT
TABLE 046. TERUMO CORPORATION: BUSINESS PERFORMANCE
TABLE 047. TERUMO CORPORATION: PRODUCT PORTFOLIO
TABLE 048. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. BIOVENTUS INC.: SNAPSHOT
TABLE 049. BIOVENTUS INC.: BUSINESS PERFORMANCE
TABLE 050. BIOVENTUS INC.: PRODUCT PORTFOLIO
TABLE 051. BIOVENTUS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. MEDTRONIC PLC.: SNAPSHOT
TABLE 052. MEDTRONIC PLC.: BUSINESS PERFORMANCE
TABLE 053. MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 054. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. ORTHOFIX INTERNATIONAL N.V: SNAPSHOT
TABLE 055. ORTHOFIX INTERNATIONAL N.V: BUSINESS PERFORMANCE
TABLE 056. ORTHOFIX INTERNATIONAL N.V: PRODUCT PORTFOLIO
TABLE 057. ORTHOFIX INTERNATIONAL N.V: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. DEPUY SYNTHES COMPANIES: SNAPSHOT
TABLE 058. DEPUY SYNTHES COMPANIES: BUSINESS PERFORMANCE
TABLE 059. DEPUY SYNTHES COMPANIES: PRODUCT PORTFOLIO
TABLE 060. DEPUY SYNTHES COMPANIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. SYNERGY ORTHOPEDICS: SNAPSHOT
TABLE 061. SYNERGY ORTHOPEDICS: BUSINESS PERFORMANCE
TABLE 062. SYNERGY ORTHOPEDICS: PRODUCT PORTFOLIO
TABLE 063. SYNERGY ORTHOPEDICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. ELIZUR CORPORATION: SNAPSHOT
TABLE 064. ELIZUR CORPORATION: BUSINESS PERFORMANCE
TABLE 065. ELIZUR CORPORATION: PRODUCT PORTFOLIO
TABLE 066. ELIZUR CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. OSSATEC BENELUX B.V.: SNAPSHOT
TABLE 067. OSSATEC BENELUX B.V.: BUSINESS PERFORMANCE
TABLE 068. OSSATEC BENELUX B.V.: PRODUCT PORTFOLIO
TABLE 069. OSSATEC BENELUX B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. DJO LLC: SNAPSHOT
TABLE 070. DJO LLC: BUSINESS PERFORMANCE
TABLE 071. DJO LLC: PRODUCT PORTFOLIO
TABLE 072. DJO LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. STRYKER CORPORATION: SNAPSHOT
TABLE 073. STRYKER CORPORATION: BUSINESS PERFORMANCE
TABLE 074. STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 075. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. ZIMMER BIOMET HOLDINGS INC.: SNAPSHOT
TABLE 076. ZIMMER BIOMET HOLDINGS INC.: BUSINESS PERFORMANCE
TABLE 077. ZIMMER BIOMET HOLDINGS INC.: PRODUCT PORTFOLIO
TABLE 078. ZIMMER BIOMET HOLDINGS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 079. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 080. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 081. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BONE GROWTH STIMULATOR MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BONE GROWTH STIMULATOR MARKET OVERVIEW BY PRODUCT
FIGURE 012. DEVICE MARKET OVERVIEW (2016-2028)
FIGURE 013. BONE MORPHOGENETIC PROTEIN MARKET OVERVIEW (2016-2028)
FIGURE 014. PLATELET-RICH PLASMA MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. BONE GROWTH STIMULATOR MARKET OVERVIEW BY APPLICATION
FIGURE 017. SPINAL FUSION SURGERIES MARKET OVERVIEW (2016-2028)
FIGURE 018. ORAL & MAXILLOFACIAL SURGERIES MARKET OVERVIEW (2016-2028)
FIGURE 019. UNION & NON-UNION BONE FRACTURES MARKET OVERVIEW (2016-2028)
FIGURE 020. OTHER MARKET OVERVIEW (2016-2028)
FIGURE 021. BONE GROWTH STIMULATOR MARKET OVERVIEW BY END USERS
FIGURE 022. HOSPITALS & ASC’S MARKET OVERVIEW (2016-2028)
FIGURE 023. HOME CARE MARKET OVERVIEW (2016-2028)
FIGURE 024. RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA BONE GROWTH STIMULATOR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE BONE GROWTH STIMULATOR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC BONE GROWTH STIMULATOR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA BONE GROWTH STIMULATOR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA BONE GROWTH STIMULATOR MARKET OVERVIEW BY COUNTRY (2016-2028)